Ga-68 NODAGA-RGD

N/A

Report date: 2025/11/20 11:38:31
NME

Base Information

Drug NameGa-68 NODAGA-RGD
Drug Alias NameGa-68 NODAGA-Theranost68Ga-TheranostTheranost 68Ga NODAGA RGDTheranost 68Ga-RGD68Ga-NODAGA-RGD +[7] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeovascularization, PathologicLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAdvanced Imaging ProjectsZentralklinik Bad BerkaNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College HospitalLausanne University Hospital
Inactive CompaniesN/A
Active IndicationsNeovascularization, PathologicLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A